title: Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream.
abstract: BACKGROUND
  Five percent imiquimod cream is FDA-approved for the treatment of genital and perianal warts and actinic Keratosis. The manufacturer recommends that a single sachet containing 250 mg of 5% imiquimod cream (12.5 mg of imiquimod) is adequate for a single use and is sufficient to cover a wart area of up to 20 cm(2).
  
  
  OBJECTIVE
  To determine the maximal area of skin that can be evenly covered by 250 mg of 5% imiquimod cream that is contained in one single-use sachet.
  
  
  METHODS
  The contents of one 250-mg single-use sachet of 5% imiquimod cream were mixed with less than 1 mg of fluorescein sodium. The cream was applied evenly onto the abdomen of two Yorkshire female pigs and onto the medial and lateral aspects of the upper left arm of a human subject. The area of application was then measured.
  
  
  RESULTS
  The average area obtained on the pig skin was 196 cm(2). The area covered on the human subject was 386 cm(2).
  
  
  CONCLUSIONS
  We have found that one sachet of 250 mg of 5% imiquimod cream can be applied to an area of skin up to 386 cm(2). In light of the increasing use of 5% imiquimod cream in the treatment of cutaneous diseases, such as actinic keratoses, which affect larger areas of skin than genital warts, a more efficient use of 5% imiquimod cream may make this medication a more cost-effective treatment modality.
authors.affiliation: Department of Dermatology and Cutaneous Surgery, University of Miami, School of Medicine, Miami, Florida 33136, USA. bberman@med.miami.edu
authors.forename: Brian
authors.initials: B
authors.lastname: Berman
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Ricotti
authors.forename: Alex
authors.initials: A
authors.lastname: Cazzaniga
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Davis
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000287:Administration, Topical; D000634:Aminoquinolines / Q000008:administration & dosage*; D000818:Animals; D003218:Condylomata Acuminata / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077271:Imiquimod; D007642:Keratosis / Q000188:drug therapy*; D013552:Swine
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod